Veterinary Medicines Information website

Clamaden 40 mg/10 mg chewable tablets for cats and dogs

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate

Product identification

Medicine name:
Clamaden 40 mg/10 mg chewable tablets for cats and dogs
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    11.91
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    45.92
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 500 tablets.
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 100 tablets.
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 20 tablets.
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 10 tablets. Carton contains 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/22/2700/001-004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0652/001
Concerned member states:
  • Belgium
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 20/09/2026
Download
Lithuanian (PDF)
Published on: 28/10/2026

Summary of Product Characteristics

English (PDF)
Published on: 13/10/2024
Updated on: 13/03/2026
Download